Interleukin-12 and protective immunity to schistosomes

Detalhes bibliográficos
Autor(a) principal: Mountford,A.P.
Data de Publicação: 1998
Outros Autores: Shires,V.L., Anderson,S.
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Brazilian Journal of Medical and Biological Research
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X1998000100023
Resumo: The attenuated vaccine against Schistosoma mansoni induces Th1-mediated protective immunity and we have sought to identify a role for IL-12 in this model. Elevated levels of IL-12 (p40 mRNA) were detected in the lymph nodes (LN) and the lungs of vaccinated mice, whilst treatment of vaccinated mice with anti-IL-12 antibodies decreased the ratio of IFN<FONT FACE="Symbol">g</font>:IL-4 secreted by in vitro-cultured LN cells. However, there was only marginal abrogation of the level of resistance in these mice. Soluble antigens from the lung-stage of the parasite (SLAP) appeared to be efficient stimulators of IFN<FONT FACE="Symbol">g</font> and IL-12 secretion. These antigens when used to immunise mice in conjunction with IL-12 as an adjuvant, elicited a polarised Th1 response with abundant IFN<FONT FACE="Symbol">g</font> secretion but no IL-4. This immunisation regime also induced significant protection against reinfection, whereas inoculation of mice with SLAP alone did not. The induction of a dominant Th1 response using SLAP + IL-12 probably operates via IFN<FONT FACE="Symbol">g</font> production by natural killer (NK) cells stimulated by IL-12, since in vivo ablation of NK cells using anti-NK1.1 antibody reduced CD4+-dependent IFN<FONT FACE="Symbol">g</font> production from cultured LN cells by over 97%. Nevertheless, in mice with a genetic disruption of the IFN<FONT FACE="Symbol">g</font> receptor, administration of SLAP + IL-12 induced levels of IFN<FONT FACE="Symbol">g</font> equal to those in wild-type mice, thus showing that in this model IL-12 can directly prime T cells independent of IFN<FONT FACE="Symbol">g</font>. Clearly, IL-12 has a critical role in protective immunity to schistosomes and it may aid the development of an effective vaccine against this disease
id ABDC-1_6bb83dfd288633be452c5f5e8bf8f779
oai_identifier_str oai:scielo:S0100-879X1998000100023
network_acronym_str ABDC-1
network_name_str Brazilian Journal of Medical and Biological Research
repository_id_str
spelling Interleukin-12 and protective immunity to schistosomesSchistosomainterleukin-12adjuvantvaccineTh1The attenuated vaccine against Schistosoma mansoni induces Th1-mediated protective immunity and we have sought to identify a role for IL-12 in this model. Elevated levels of IL-12 (p40 mRNA) were detected in the lymph nodes (LN) and the lungs of vaccinated mice, whilst treatment of vaccinated mice with anti-IL-12 antibodies decreased the ratio of IFN<FONT FACE="Symbol">g</font>:IL-4 secreted by in vitro-cultured LN cells. However, there was only marginal abrogation of the level of resistance in these mice. Soluble antigens from the lung-stage of the parasite (SLAP) appeared to be efficient stimulators of IFN<FONT FACE="Symbol">g</font> and IL-12 secretion. These antigens when used to immunise mice in conjunction with IL-12 as an adjuvant, elicited a polarised Th1 response with abundant IFN<FONT FACE="Symbol">g</font> secretion but no IL-4. This immunisation regime also induced significant protection against reinfection, whereas inoculation of mice with SLAP alone did not. The induction of a dominant Th1 response using SLAP + IL-12 probably operates via IFN<FONT FACE="Symbol">g</font> production by natural killer (NK) cells stimulated by IL-12, since in vivo ablation of NK cells using anti-NK1.1 antibody reduced CD4+-dependent IFN<FONT FACE="Symbol">g</font> production from cultured LN cells by over 97%. Nevertheless, in mice with a genetic disruption of the IFN<FONT FACE="Symbol">g</font> receptor, administration of SLAP + IL-12 induced levels of IFN<FONT FACE="Symbol">g</font> equal to those in wild-type mice, thus showing that in this model IL-12 can directly prime T cells independent of IFN<FONT FACE="Symbol">g</font>. Clearly, IL-12 has a critical role in protective immunity to schistosomes and it may aid the development of an effective vaccine against this diseaseAssociação Brasileira de Divulgação Científica1998-01-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X1998000100023Brazilian Journal of Medical and Biological Research v.31 n.1 1998reponame:Brazilian Journal of Medical and Biological Researchinstname:Associação Brasileira de Divulgação Científica (ABDC)instacron:ABDC10.1590/S0100-879X1998000100023info:eu-repo/semantics/openAccessMountford,A.P.Shires,V.L.Anderson,S.eng1998-10-07T00:00:00Zoai:scielo:S0100-879X1998000100023Revistahttps://www.bjournal.org/https://old.scielo.br/oai/scielo-oai.phpbjournal@terra.com.br||bjournal@terra.com.br1414-431X0100-879Xopendoar:1998-10-07T00:00Brazilian Journal of Medical and Biological Research - Associação Brasileira de Divulgação Científica (ABDC)false
dc.title.none.fl_str_mv Interleukin-12 and protective immunity to schistosomes
title Interleukin-12 and protective immunity to schistosomes
spellingShingle Interleukin-12 and protective immunity to schistosomes
Mountford,A.P.
Schistosoma
interleukin-12
adjuvant
vaccine
Th1
title_short Interleukin-12 and protective immunity to schistosomes
title_full Interleukin-12 and protective immunity to schistosomes
title_fullStr Interleukin-12 and protective immunity to schistosomes
title_full_unstemmed Interleukin-12 and protective immunity to schistosomes
title_sort Interleukin-12 and protective immunity to schistosomes
author Mountford,A.P.
author_facet Mountford,A.P.
Shires,V.L.
Anderson,S.
author_role author
author2 Shires,V.L.
Anderson,S.
author2_role author
author
dc.contributor.author.fl_str_mv Mountford,A.P.
Shires,V.L.
Anderson,S.
dc.subject.por.fl_str_mv Schistosoma
interleukin-12
adjuvant
vaccine
Th1
topic Schistosoma
interleukin-12
adjuvant
vaccine
Th1
description The attenuated vaccine against Schistosoma mansoni induces Th1-mediated protective immunity and we have sought to identify a role for IL-12 in this model. Elevated levels of IL-12 (p40 mRNA) were detected in the lymph nodes (LN) and the lungs of vaccinated mice, whilst treatment of vaccinated mice with anti-IL-12 antibodies decreased the ratio of IFN<FONT FACE="Symbol">g</font>:IL-4 secreted by in vitro-cultured LN cells. However, there was only marginal abrogation of the level of resistance in these mice. Soluble antigens from the lung-stage of the parasite (SLAP) appeared to be efficient stimulators of IFN<FONT FACE="Symbol">g</font> and IL-12 secretion. These antigens when used to immunise mice in conjunction with IL-12 as an adjuvant, elicited a polarised Th1 response with abundant IFN<FONT FACE="Symbol">g</font> secretion but no IL-4. This immunisation regime also induced significant protection against reinfection, whereas inoculation of mice with SLAP alone did not. The induction of a dominant Th1 response using SLAP + IL-12 probably operates via IFN<FONT FACE="Symbol">g</font> production by natural killer (NK) cells stimulated by IL-12, since in vivo ablation of NK cells using anti-NK1.1 antibody reduced CD4+-dependent IFN<FONT FACE="Symbol">g</font> production from cultured LN cells by over 97%. Nevertheless, in mice with a genetic disruption of the IFN<FONT FACE="Symbol">g</font> receptor, administration of SLAP + IL-12 induced levels of IFN<FONT FACE="Symbol">g</font> equal to those in wild-type mice, thus showing that in this model IL-12 can directly prime T cells independent of IFN<FONT FACE="Symbol">g</font>. Clearly, IL-12 has a critical role in protective immunity to schistosomes and it may aid the development of an effective vaccine against this disease
publishDate 1998
dc.date.none.fl_str_mv 1998-01-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X1998000100023
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X1998000100023
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/S0100-879X1998000100023
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Associação Brasileira de Divulgação Científica
publisher.none.fl_str_mv Associação Brasileira de Divulgação Científica
dc.source.none.fl_str_mv Brazilian Journal of Medical and Biological Research v.31 n.1 1998
reponame:Brazilian Journal of Medical and Biological Research
instname:Associação Brasileira de Divulgação Científica (ABDC)
instacron:ABDC
instname_str Associação Brasileira de Divulgação Científica (ABDC)
instacron_str ABDC
institution ABDC
reponame_str Brazilian Journal of Medical and Biological Research
collection Brazilian Journal of Medical and Biological Research
repository.name.fl_str_mv Brazilian Journal of Medical and Biological Research - Associação Brasileira de Divulgação Científica (ABDC)
repository.mail.fl_str_mv bjournal@terra.com.br||bjournal@terra.com.br
_version_ 1754302929170333696